Matthew W. Towse, Chief Financial Officer at NxStage Medical, Inc. (NXTM), sold 228 shares at $13.44 ($3K) on 2014-07-16, disclosed to the SEC on 2014-07-22.
Open-market sale of $3k NXTM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NXTM | SELL | 2017-08-23 | $126K | — | Filing → |
| NXTM | SELL | 2017-07-21 | $104K | — | Filing → |
| NXTM | SELL | 2017-06-21 | $100K | — | Filing → |